CalcimedicaCALC
13F holders, Q1 2024 (March 31)20holders
1famous investor
$4.16avg. 13F price*
At the end of Q1 2024, 20 institutions reported holding Calcimedica Inc. (CALC) in their 13F filings. The largest holders were Deerfield Management Company, L.P. ($4.2M), Soleus Capital Management, L.P. ($3.3M) and Stonepine Capital Management, LLC ($2.2M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Calcimedica Inc.
- CUSIP
- 38942Q202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $12.4M |
| Exits | 1 | $0 |
Ownership 20 holders
| Deerfield Management Company, L.P. | 0.08% | New | 1,000,000 | $4.2M |
| Soleus Capital Management, L.P. | 0.29% | New | 783,904 | $3.3M |
| Stonepine Capital Management, LLC | 1.72% | New | 522,602 | $2.2M |
| Aisling Capital Management LP | 0.73% | New | 521,114 | $2.2M |
| Orbimed Advisors LLC | 0.02% | No change | 297,380 | $1.2M |
| BML Capital Management, LLC | 0.45% | Add +10.3% | 160,424 | $667K |
| Alyeska Investment Group, L.P. | 0.00% | New | 75,082 | $312K |
| Millennium Management | 0.00% | New | 66,134 | $275K |
| Meritage Portfolio Management | 0.01% | No change | 46,000 | $191K |
| Geode Capital Management, LLC | 0.00% | Add +234.6% | 44,686 | $186K |
| Vanguard Group Inc. | 0.00% | New | 13,359 | $56K |
| First Manhattan Co. Llc. | 0.00% | No change | 13,226 | $55K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +53.9% | 2,181 | $11K |
| Qube Research & Technologies Ltd | 0.00% | Add +122800.0% | 1,229 | $5K |
| Morgan Stanley | 0.00% | No change | 856 | $4K |
| ADAR1 Capital Management, LLC | 0.00% | New | 781 | $3K |
| Bank of America Corp. | 0.00% | No change | 507 | $2K |
| Wells Fargo & Company | 0.00% | Add +243.8% | 55 | $229 |
| UBS Group AG | 0.00% | Add +14.3% | 16 | $66 |
| JPMorgan Chase & Co. | 0.00% | New | 14 | $58 |
"% of holder's portfolio" is CALC's weight in each manager's 13F, not the share of Calcimedica Inc. the manager owns.